Today’s life insurance
companies face unprecedented business challenges and opportunities.
Escalating competition, capital constraints, and rising customer
expectations combine to increasingly squeeze profitability. To remain
competitive, carriers need new, cost-effective solutions such as
Biosignia’s Mortality Assessment Technology to provide more accurate
risk classifications which will improve the bottom line.
By using MAT, one can measure mortality risk in relative terms to
improve the consistency of risk classification across different age
groups. MAT overcomes the drawbacks of conventional classification,
which uses “knock-out” criteria vs. looking at the mortality risk in
totality. MAT uniquely uses biological and clinical information to
provide quantitative mortality assessment in a consistent and objective
manner using cutting-edge predictive technology and evidence-based
medical science to predict mortality.
MAT™ Mortality Assestment Technology
Copyright 2008 © BioSignia, Inc. All Rights Reserved
